Kingsview Wealth Management LLC purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The firm purchased 80,440 shares of the company’s stock, valued at approximately $10,337,000.
Other institutional investors have also modified their holdings of the company. Bank of America Corp DE purchased a new stake in shares of Merck KGaA in the 2nd quarter valued at $3,923,774,000. Legal & General Group Plc acquired a new position in Merck KGaA during the 2nd quarter worth about $2,425,225,000. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in Merck KGaA during the 2nd quarter valued at about $942,087,000. Caisse de depot et placement du Quebec purchased a new position in Merck KGaA during the 2nd quarter valued at about $571,582,000. Finally, Canada Pension Plan Investment Board purchased a new position in Merck KGaA during the 2nd quarter valued at about $536,694,000. 0.10% of the stock is owned by institutional investors and hedge funds.
Merck KGaA Stock Performance
OTCMKTS MKGAF opened at $164.12 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The company has a market cap of $21.21 billion, a P/E ratio of 25.06 and a beta of 0.96. The stock has a 50-day moving average of $163.35 and a two-hundred day moving average of $149.06. Merck KGaA has a 1-year low of $116.68 and a 1-year high of $175.56.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
